An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model (Clin Infect Dis 2015; 61(S1):doi:10.1093/cid/civ650)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.